Articles related to MEDICAL UNIVERSITY PRESS

Discover how the FLAURA2 trial’s findings on combination therapy could revolutionize initial treatment plans for NSCLC patients with EGFR mutations. Learn more about the significant extension in progression-free survival and its potential clinical implications.

Discover how Roswell Park’s phase 2 clinical trials are exploring the potential of propranolol to enhance the efficacy of immunotherapies in treating esophageal cancer. This could represent a significant shift in treatment protocols.

Discover how sacituzumab govitecan is setting a new standard in the treatment of HR+, HER2- metastatic breast cancer, offering improved survival rates and lower risks of progression.

Explore the potential of OncoNPC, an AI model that leverages gene sequencing data to predict the primary source of cancer, offering a new avenue for more targeted and effective treatments.

The Icahn School of Medicine at Mount Sinai has launched a pioneering center dedicated to the advancement of AI in ophthalmology. This initiative aims to transform patient care and research, focusing on early detection and intervention of various eye diseases and related systemic conditions.

Northwestern Medicine’s recent study uncovers a novel interaction between lysosomes and mitochondria, disrupted by mutations in the parkin gene, contributing to Parkinson’s disease. This discovery offers a new therapeutic pathway and emphasizes the significance of organelle communication in neurodegenerative disorders.